Publication: Impact of ISUP grade group on cancer-specific mortality in radical prostatectomy-treated prostate cancer patients with organ-confined disease
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Barletta, Francesco
Tappero, Stefano
Morra, Simone
Incesu, Reha-Baris
Garcia, Cristina Cano
Piccinelli, Mattia Luca
Scheipner, Lukas
Tian, Zhe
Gandaglia, Giorgio
Stabile, Armando
Date
Language
Type
Embargo Status
No
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
INTRODUCTION: We aimed to test the impact of International Society of Urological Pathology (ISUP) grade group (GG) on cancer-specific mortality (CSM) in organ-confined (pT2) prostate cancer (PCa) at radical prostatectomy (RP). METHODS: RP organ-confined PCa patients were identified (Surveillance, Epidemiology, and End Results [SEER] 2004-2015). Cancer-specific survival (CSS) rates were tested in Kaplan-Meier plots and multivariable Cox regression (MCR) models according to GG: 1-3 vs. 4 vs. 5. Sensitivity analyses addressed GG4 and GG5 patients with available primary and secondary Gleason score (GS). RESULTS: Overall, 61 172 patients with RP organ-confined PCa were identified. Of these, 57 715 (94.4%), 2036 (3.3%) and 1421 (2.3%) harbored GG1-3, 4, and 5, respectively. In Kaplan-Meier analyses, seven-year' CSS estimates were 99.6 vs. 98.2 vs. 93.8% for GG1-3 vs. 4 vs. 5, respectively (p<0.001). In MCR models, GG4 (hazard ratio [HR] 2.72, p<0.001) and 5 (HR 9.95, p<0.001) independently predicted higher CSM, relative to GG1-3. Furthermore, GG5 also independently predicted higher CSM (HR 3.72, p<0.001) vs. GG4. In sensitivity analyses, 1.2, 1.6, and 2.4 CSM events per 1000 person-years of followup were respectively recorded for GS 4+4, 3+5, and 5+3 patients. Conversely, 4.8 vs. 5.3 CSM events per 1000 person-years of followup were respectively recorded for GS 4+5 vs. 5+4/5+5 patients. CONCLUSIONS: In organ-confined PCa, at RP, a small proportion of patients harbor GG4-5. These patients exhibit higher CSM than their GG1-3 counterparts. Moreover, detectable mortality rate differences indicate a dose-response effect according to primary and secondary GS. This phenomenon applies in both GG4 and GG5, as well as between GG4 and GG5.
Source
Publisher
Canadian Urological Association
Subject
Citation
item.page.haspartof
Source
Canadian Urological Association Journal
item.page.ispartofseries
item.page.edition
DOI
10.5489/cuaj.8941
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
